You are about to undo an edit. Please check the comparison below to verify that this is what you want to do, then publish the changes below to finish undoing the edit. If you are undoing an edit that is not vandalism, explain the reason in the edit summary. Do not use the default message only. |
Latest revision | Your text | ||
Line 66: | Line 66: | ||
<small>D</small>-β-Hydroxybutyric acid, along with [[butyric acid]], are the two primary [[endogenous]] [[agonist]]s of [[hydroxycarboxylic acid receptor 2]] (HCA<sub>2</sub>), a {{nowrap|[[Gi alpha subunit|G<sub>i/o</sub>-coupled]]}} [[GPCR]].<ref name="IUPHAR's comprehensive 2011 review on HCARs"/><ref name="IUPHAR-DB HCAR family page"/><ref name="β-D-hydroxybutyric acid IUPHAR">{{cite web|title=β-D-hydroxybutyric acid: Biological activity|url=http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=biology&ligandId=1593|website=IUPHAR/BPS Guide to Pharmacology|publisher=International Union of Basic and Clinical Pharmacology|access-date=5 February 2018}}</ref> |
<small>D</small>-β-Hydroxybutyric acid, along with [[butyric acid]], are the two primary [[endogenous]] [[agonist]]s of [[hydroxycarboxylic acid receptor 2]] (HCA<sub>2</sub>), a {{nowrap|[[Gi alpha subunit|G<sub>i/o</sub>-coupled]]}} [[GPCR]].<ref name="IUPHAR's comprehensive 2011 review on HCARs"/><ref name="IUPHAR-DB HCAR family page"/><ref name="β-D-hydroxybutyric acid IUPHAR">{{cite web|title=β-D-hydroxybutyric acid: Biological activity|url=http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=biology&ligandId=1593|website=IUPHAR/BPS Guide to Pharmacology|publisher=International Union of Basic and Clinical Pharmacology|access-date=5 February 2018}}</ref> |
||
β-Hydroxybutyric acid is able to cross the [[blood-brain-barrier]] into the [[central nervous system]].<ref name="pmid27253067">{{cite journal | vauthors = Sleiman SF, Henry J, Al-Haddad R, El Hayek L, Abou Haidar E, Stringer T, Ulja D, Karuppagounder SS, Holson EB, Ratan RR, Ninan I, Chao MV | display-authors = 6 | title = Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate | journal = eLife | volume = 5 | date = June 2016 | pmid = 27253067 | pmc = 4915811 | doi = 10.7554/eLife.15092 |
β-Hydroxybutyric acid is able to cross the [[blood-brain-barrier]] into the [[central nervous system]].<ref name="pmid27253067">{{cite journal | vauthors = Sleiman SF, Henry J, Al-Haddad R, El Hayek L, Abou Haidar E, Stringer T, Ulja D, Karuppagounder SS, Holson EB, Ratan RR, Ninan I, Chao MV | display-authors = 6 | title = Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate | journal = eLife | volume = 5 | date = June 2016 | pmid = 27253067 | pmc = 4915811 | doi = 10.7554/eLife.15092 }}</ref> Levels of β-hydroxybutyric acid increase in the [[liver]], [[heart]], [[muscle]], [[brain]], and other tissues with [[exercise]], [[calorie restriction]], [[fasting]], and [[ketogenic diet]]s.<ref name="pmid27253067" /> The compound has been found to act as a [[histone deacetylase inhibitor|histone deacetylase (HDAC) inhibitor]].<ref name="pmid27253067" /> Through inhibition of the HDAC class I [[isoenzyme]]s [[HDAC2]] and [[HDAC3]], β-hydroxybutyric acid has been found to increase [[brain-derived neurotrophic factor]] (BDNF) levels and [[TrkB]] [[cell signaling|signaling]] in the [[hippocampus]].<ref name="pmid27253067" /> Moreover, a rodent study found that prolonged exercise increases plasma β-hydroxybutyrate concentrations, which induces [[promoter (genetics)|promoters]] of the BDNF gene in the hippocampus.<ref name="pmid27253067" /> These findings may have clinical relevance in the treatment of [[depression (mood)|depression]], [[anxiety]], and [[cognitive impairment]].<ref name="pmid27253067"/> |
||
In [[epilepsy]] patients on the ketogenic diet, blood β-hydroxybutyrate levels correlate best with degree of [[seizure]] control. The threshold for optimal [[anticonvulsant]] effect appears to be approximately 4 mmol/L.<ref name="pmid11198492">{{cite journal | vauthors = Gilbert DL, Pyzik PL, Freeman JM | title = The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones | journal = Journal of Child Neurology | volume = 15 | issue = 12 | pages = 787–790 | date = December 2000 | pmid = 11198492 | doi = 10.1177/088307380001501203 | s2cid = 46659339 }}</ref> |
In [[epilepsy]] patients on the ketogenic diet, blood β-hydroxybutyrate levels correlate best with degree of [[seizure]] control. The threshold for optimal [[anticonvulsant]] effect appears to be approximately 4 mmol/L.<ref name="pmid11198492">{{cite journal | vauthors = Gilbert DL, Pyzik PL, Freeman JM | title = The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones | journal = Journal of Child Neurology | volume = 15 | issue = 12 | pages = 787–790 | date = December 2000 | pmid = 11198492 | doi = 10.1177/088307380001501203 | s2cid = 46659339 }}</ref> |
Copy and paste: – — ° ′ ″ ≈ ≠ ≤ ≥ ± − × ÷ ← → · § Cite your sources: <ref></ref>
{{}} {{{}}} | [] [[]] [[Category:]] #REDIRECT [[]] <s></s> <sup></sup> <sub></sub> <code></code> <pre></pre> <blockquote></blockquote> <ref></ref> <ref name="" /> {{Reflist}} <references /> <includeonly></includeonly> <noinclude></noinclude> {{DEFAULTSORT:}} <nowiki></nowiki> <!-- --> <span class="plainlinks"></span>
Symbols: ~ | ¡ ¿ † ‡ ↔ ↑ ↓ • ¶ # ∞ ‹› «» ¤ ₳ ฿ ₵ ¢ ₡ ₢ $ ₫ ₯ € ₠ ₣ ƒ ₴ ₭ ₤ ℳ ₥ ₦ № ₧ ₰ £ ៛ ₨ ₪ ৳ ₮ ₩ ¥ ♠ ♣ ♥ ♦ 𝄫 ♭ ♮ ♯ 𝄪 © ® ™
Latin: A a Á á À à  â Ä ä Ǎ ǎ Ă ă Ā ā à ã Å å Ą ą Æ æ Ǣ ǣ B b C c Ć ć Ċ ċ Ĉ ĉ Č č Ç ç D d Ď ď Đ đ Ḍ ḍ Ð ð E e É é È è Ė ė Ê ê Ë ë Ě ě Ĕ ĕ Ē ē Ẽ ẽ Ę ę Ẹ ẹ Ɛ ɛ Ǝ ǝ Ə ə F f G g Ġ ġ Ĝ ĝ Ğ ğ Ģ ģ H h Ĥ ĥ Ħ ħ Ḥ ḥ I i İ ı Í í Ì ì Î î Ï ï Ǐ ǐ Ĭ ĭ Ī ī Ĩ ĩ Į į Ị ị J j Ĵ ĵ K k Ķ ķ L l Ĺ ĺ Ŀ ŀ Ľ ľ Ļ ļ Ł ł Ḷ ḷ Ḹ ḹ M m Ṃ ṃ N n Ń ń Ň ň Ñ ñ Ņ ņ Ṇ ṇ Ŋ ŋ O o Ó ó Ò ò Ô ô Ö ö Ǒ ǒ Ŏ ŏ Ō ō Õ õ Ǫ ǫ Ọ ọ Ő ő Ø ø Œ œ Ɔ ɔ P p Q q R r Ŕ ŕ Ř ř Ŗ ŗ Ṛ ṛ Ṝ ṝ S s Ś ś Ŝ ŝ Š š Ş ş Ș ș Ṣ ṣ ß T t Ť ť Ţ ţ Ț ț Ṭ ṭ Þ þ U u Ú ú Ù ù Û û Ü ü Ǔ ǔ Ŭ ŭ Ū ū Ũ ũ Ů ů Ų ų Ụ ụ Ű ű Ǘ ǘ Ǜ ǜ Ǚ ǚ Ǖ ǖ V v W w Ŵ ŵ X x Y y Ý ý Ŷ ŷ Ÿ ÿ Ỹ ỹ Ȳ ȳ Z z Ź ź Ż ż Ž ž ß Ð ð Þ þ Ŋ ŋ Ə ə
Greek: Ά ά Έ έ Ή ή Ί ί Ό ό Ύ ύ Ώ ώ Α α Β β Γ γ Δ δ Ε ε Ζ ζ Η η Θ θ Ι ι Κ κ Λ λ Μ μ Ν ν Ξ ξ Ο ο Π π Ρ ρ Σ σ ς Τ τ Υ υ Φ φ Χ χ Ψ ψ Ω ω {{Polytonic|}}
Cyrillic: А а Б б В в Г г Ґ ґ Ѓ ѓ Д д Ђ ђ Е е Ё ё Є є Ж ж З з Ѕ ѕ И и І і Ї ї Й й Ј ј К к Ќ ќ Л л Љ љ М м Н н Њ њ О о П п Р р С с Т т Ћ ћ У у Ў ў Ф ф Х х Ц ц Ч ч Џ џ Ш ш Щ щ Ъ ъ Ы ы Ь ь Э э Ю ю Я я ́
IPA: t̪ d̪ ʈ ɖ ɟ ɡ ɢ ʡ ʔ ɸ β θ ð ʃ ʒ ɕ ʑ ʂ ʐ ç ʝ ɣ χ ʁ ħ ʕ ʜ ʢ ɦ ɱ ɳ ɲ ŋ ɴ ʋ ɹ ɻ ɰ ʙ ⱱ ʀ ɾ ɽ ɫ ɬ ɮ ɺ ɭ ʎ ʟ ɥ ʍ ɧ ʼ ɓ ɗ ʄ ɠ ʛ ʘ ǀ ǃ ǂ ǁ ɨ ʉ ɯ ɪ ʏ ʊ ø ɘ ɵ ɤ ə ɚ ɛ œ ɜ ɝ ɞ ʌ ɔ æ ɐ ɶ ɑ ɒ ʰ ʱ ʷ ʲ ˠ ˤ ⁿ ˡ ˈ ˌ ː ˑ ̪ {{IPA|}}
Wikidata entities used in this page
Pages transcluded onto the current version of this page (help):
This page is a member of 11 hidden categories (help):